ABAnna Brunet

Anna Brunet

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna Brunet has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Elisabeth Gabau

    Paediatric Unit, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain

    1 shared publication
  • Lluís Armengol

    Genes and Disease Program, Center for Genomic Regulation, Barcelona, Spain

    1 shared publication
  • Miriam Guitart

    Genetics Unit, Laboratory Service, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain

    1 shared publication
  • Roser Guillamat

    Department of Mental Health, Consorci Sanitari de Terrassa, Terrassa, Catalonia, Spain

    1 shared publication
  • Trini Pelaez

    Genetic laboratory UDIAT-Centre Diagnòstic, Department of Mental Health Department of Paediatrics, Fundació Parc Taulí – Institut Universitari UAB, Corporació Sanitària Parc Taulí, Sabadell, Catalonia, Spain

    1 shared publication
  • Vicenç Vallès

    Behavioral Addictions Unit, Area of Mental Health Care, Consorci Sanitari de Terrassa, 08227 Terrassa, Spain

    1 shared publication

Latest Publications

  • Open Access

    Failure to detect the 22q11.2 duplication syndrome rearrangement among patients with schizophrenia

    by Anna Brunet, Lluís Armengol, Trini Pelaez, Roser Guillamat, Vicenç Vallès, Elisabeth Gabau, Xavier Estivill, Miriam Guitart

    Chromosome aberrations have long been studied in an effort to identify susceptibility genes for schizophrenia. Chromosome 22q11.2 microdeletion is associated with DiGeorge and Velocardiofacial syndromes (DG/VCF) and provides the most convincing evidence of an association between molecular cytogenetic abnormality and schizophrenia. In addition, this region is one of the best replicated linkage findings for schizophrenia. Recently, the reciprocal microduplication on 22q11.2 has been reported as a new syndrome. Preliminary data indicates that individuals with these duplications also suffer from neuropsychiatric disorders. In this study we have investigated the appropriateness of testing schizophrenia patients for the 22q11.2 microduplication. We used multiplex ligation-dependent probe amplification (MLPA) to measure copy number changes on the 22q11.2 region in a sample of 190 patients with schizophrenia. Our results corroborate the prevalence of the 22q11.2 microdeletion in patients with schizophrenia and clinical features of DG/VCFS and do not suggest an association between 22q11.2 microduplication and schizophrenia.